Winnergy Medical Public Company Limited (WINMED) recently hosted an event to highlight the progress of its Thermogram breast cancer screening program, an advanced screening solution powered by artificial intelligence (AI). The program has now provided breast health screening to more than 3,000 women in Thailand, reflecting a significant milestone in WINMED’s ongoing efforts to promote early detection and preventive healthcare.

The event was presided over by Mr. Nantiya Darakanont, Chief Executive Officer, with Ms. Sarisa Kodsanee, Assistant Vice President, serving as Head of the Thermogram Project, overseeing the program’s strategic direction and continuous implementation.

Thermogram is not conventional thermography. Instead, Thermogram is a next-generation breast cancer screening system powered by artificial intelligence (AI). It analyzes functional thermal imaging data in combination with individual health data to assess breast health risk in a structured, systematic manner.

The technology used in the Thermogram system is Thermalytix® AI, which detects abnormal thermal patterns associated with underlying physiological changes. Importantly, Thermogram does not directly image breast tissue.

Through the continued development of Thermogram, WINMED reaffirms its position in advancing safe, accessible, and evidence-based breast cancer screening solutions, contributing to improved long-term health outcomes and quality of life for women in Thailand.